Harel Insurance Investments & Financial Services Ltd. Has $1.07 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)


Share on StockTwits

Harel Insurance Investments & Financial Services Ltd. cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 44.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 437 shares of the medical equipment provider’s stock after selling 345 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Intuitive Surgical were worth $1,070,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of ISRG. Norges Bank bought a new position in Intuitive Surgical in the 4th quarter valued at about $852,020,000. Assenagon Asset Management S.A. boosted its position in shares of Intuitive Surgical by 1,432.3% during the first quarter. Assenagon Asset Management S.A. now owns 92,753 shares of the medical equipment provider’s stock valued at $68,539,000 after buying an additional 86,700 shares during the last quarter. Korea Investment CORP grew its holdings in Intuitive Surgical by 39.2% during the fourth quarter. Korea Investment CORP now owns 298,239 shares of the medical equipment provider’s stock worth $243,989,000 after buying an additional 83,989 shares in the last quarter. Jennison Associates LLC raised its position in Intuitive Surgical by 8.7% in the 4th quarter. Jennison Associates LLC now owns 973,997 shares of the medical equipment provider’s stock valued at $796,827,000 after buying an additional 77,641 shares during the last quarter. Finally, FIL Ltd boosted its holdings in Intuitive Surgical by 585,215.4% during the 4th quarter. FIL Ltd now owns 76,091 shares of the medical equipment provider’s stock worth $62,250,000 after acquiring an additional 76,078 shares during the last quarter. 86.50% of the stock is currently owned by institutional investors and hedge funds.

In other news, EVP Curet Myriam sold 875 shares of the company’s stock in a transaction on Monday, April 26th. The stock was sold at an average price of $866.44, for a total value of $758,135.00. Following the completion of the sale, the executive vice president now directly owns 969 shares in the company, valued at approximately $839,580.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Marshall Mohr sold 21,963 shares of the firm’s stock in a transaction on Monday, April 26th. The stock was sold at an average price of $865.69, for a total value of $19,013,149.47. Following the completion of the transaction, the chief financial officer now directly owns 9,375 shares in the company, valued at $8,115,843.75. The disclosure for this sale can be found here. Over the last three months, insiders sold 31,780 shares of company stock valued at $26,987,343. 1.60% of the stock is owned by insiders.

ISRG has been the subject of a number of recent analyst reports. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $879.00 to $892.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 21st. Raymond James upped their price objective on Intuitive Surgical from $800.00 to $865.00 and gave the company an “outperform” rating in a research note on Friday, January 22nd. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $840.00 to $900.00 and gave the company an “overweight” rating in a research report on Wednesday, April 21st. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell increased their target price on shares of Intuitive Surgical from $862.00 to $939.00 and gave the company a “buy” rating in a research report on Tuesday, April 27th. Finally, Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $804.00 price target on the stock in a report on Tuesday, April 6th. Eight analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Intuitive Surgical has a consensus rating of “Buy” and a consensus price target of $805.95.

ISRG opened at $867.55 on Tuesday. The firm has a market capitalization of $102.73 billion, a price-to-earnings ratio of 98.81, a PEG ratio of 8.96 and a beta of 0.98. Intuitive Surgical, Inc. has a one year low of $495.55 and a one year high of $893.79. The business has a 50 day simple moving average of $780.58 and a two-hundred day simple moving average of $763.55.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Monday, April 19th. The medical equipment provider reported $3.52 EPS for the quarter, topping analysts’ consensus estimates of $2.63 by $0.89. The company had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.11 billion. Intuitive Surgical had a return on equity of 12.08% and a net margin of 24.45%. The firm’s revenue was up 17.5% on a year-over-year basis. During the same quarter last year, the firm posted $2.69 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post 8.02 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

See Also: Why are trading ranges significant?

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.